Showing results (61-70 of 108) with videos related to

Sort By:
Pageof 11
Journal of Leukocyte Biology|February 28, 2002
Engagement of alpha4beta1 integrin by fibronectin induces in vitro resistance of B chronic lymphocytic leukemia cells to fludarabineMaria Teresa de la Fuente, Benito Casanova, José V Moyano, et al.
ACS Applied Materials & Interfaces|February 15, 2021
Iron Oxide Nanoparticle Coatings Dictate Cell Outcomes Despite the Influence of Protein CoronasYadileiny Portilla, Sara Mellid, Alberto Paradela, et al.
Microbial Cell Factories|August 13, 2014
Efficient production of single-chain fragment variable-based N-terminal trimerbodies in Pichia pastorisAna Blanco-Toribio, Javier Lacadena, Natalia Nuñez-Prado, et al.
Plos One|June 23, 2012
The heterotrimeric laminin coiled-coil domain exerts anti-adhesive effects and induces a pro-invasive phenotypePatricia Santos-Valle, Irene Guijarro-Muñoz, Angel M Cuesta, et al.
Microvascular Research|February 7, 2008
Long-term in vivo imaging of human angiogenesis: critical role of bone marrow-derived mesenchymal stem cells for the generation of durable blood vesselsLaura Sanz, Patricia Santos-Valle, Vanesa Alonso-Camino, et al.
Toxicology and Applied Pharmacology|May 13, 2024
Pharmacokinetics and safety of LEAD-452, an EGFR-specific 4-1BB-agonistic trimerbody in non-human primatesRocío Navarro, Susana Frago, Oana Hangiu, et al.
Journal of Immunological Methods|October 16, 2008
Functionally fused antibodies--a novel adjuvant fusion systemMartin Larsen, Kim Bak Jensen, Peter Astrup Christensen, et al.
Mabs|March 29, 2012
Improved stability of multivalent antibodies containing the human collagen XV trimerization domainAngel M Cuesta, David Sánchez-Martín, Ana Blanco-Toribio, et al.
Cancer Immunology, Immunotherapy : CII|June 6, 2018
Bispecific light T-cell engagers for gene-based immunotherapy of epidermal growth factor receptor (EGFR)-positive malignanciesKasper Mølgaard, Seandean L Harwood, Marta Compte, et al.
British Journal of Clinical Pharmacology|February 17, 2025
First-in-human safety, tolerability, pharmacokinetics and pilot food-effect study of the candidate antimalarial compound MMV367Andrea Kuemmerle, Nand Singh, Denis Gossen, et al.
Pageof 11